605 related articles for article (PubMed ID: 18539959)
41. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis.
Eyler CE; Rich JN
J Clin Oncol; 2008 Jun; 26(17):2839-45. PubMed ID: 18539962
[TBL] [Abstract][Full Text] [Related]
42. Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance.
Palomeras S; Ruiz-Martínez S; Puig T
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200262
[TBL] [Abstract][Full Text] [Related]
43. Cancer stem cells and human malignant melanoma.
Schatton T; Frank MH
Pigment Cell Melanoma Res; 2008 Feb; 21(1):39-55. PubMed ID: 18353142
[TBL] [Abstract][Full Text] [Related]
44. Cancer stem cells: how can we target them?
Ischenko I; Seeliger H; Schaffer M; Jauch KW; Bruns CJ
Curr Med Chem; 2008; 15(30):3171-84. PubMed ID: 19075661
[TBL] [Abstract][Full Text] [Related]
45. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
Zardawi SJ; O'Toole SA; Sutherland RL; Musgrove EA
Histol Histopathol; 2009 Mar; 24(3):385-98. PubMed ID: 19130408
[TBL] [Abstract][Full Text] [Related]
46. Cancer stem cells in breast cancer.
Dittmer J; Rody A
Histol Histopathol; 2013 Jul; 28(7):827-38. PubMed ID: 23468411
[TBL] [Abstract][Full Text] [Related]
47. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
Yang Y; Leonard M; Zhang Y; Zhao D; Mahmoud C; Khan S; Wang J; Lower EE; Zhang X
Cancer Res; 2018 Jan; 78(2):422-435. PubMed ID: 29187405
[TBL] [Abstract][Full Text] [Related]
48. Cancer stem cells and the ontogeny of lung cancer.
Peacock CD; Watkins DN
J Clin Oncol; 2008 Jun; 26(17):2883-9. PubMed ID: 18539968
[TBL] [Abstract][Full Text] [Related]
49. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
[TBL] [Abstract][Full Text] [Related]
50. Differentiation pathways in carcinogenesis and in chemo- and radioresistance.
Janikova M; Skarda J
Neoplasma; 2012; 59(1):6-17. PubMed ID: 22017591
[TBL] [Abstract][Full Text] [Related]
51. An update on the biology of cancer stem cells in breast cancer.
García Bueno JM; Ocaña A; Castro-García P; Gil Gas C; Sánchez-Sánchez F; Poblet E; Serrano R; Calero R; Ramírez-Castillejo C
Clin Transl Oncol; 2008 Dec; 10(12):786-93. PubMed ID: 19068449
[TBL] [Abstract][Full Text] [Related]
52. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.
Ischenko I; Seeliger H; Kleespies A; Angele MK; Eichhorn ME; Jauch KW; Bruns CJ
Langenbecks Arch Surg; 2010 Jan; 395(1):1-10. PubMed ID: 19421768
[TBL] [Abstract][Full Text] [Related]
53. The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers.
Liang Y; Yang L; Xie J
Cells; 2021 Aug; 10(8):. PubMed ID: 34440799
[TBL] [Abstract][Full Text] [Related]
54. Human colon cancer stem cells: a new paradigm in gastrointestinal oncology.
Boman BM; Huang E
J Clin Oncol; 2008 Jun; 26(17):2828-38. PubMed ID: 18539961
[TBL] [Abstract][Full Text] [Related]
55. Molecular biology of breast cancer stem cells: potential clinical applications.
Nguyen NP; Almeida FS; Chi A; Nguyen LM; Cohen D; Karlsson U; Vinh-Hung V
Cancer Treat Rev; 2010 Oct; 36(6):485-91. PubMed ID: 20231058
[TBL] [Abstract][Full Text] [Related]
56. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
[TBL] [Abstract][Full Text] [Related]
57. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
[TBL] [Abstract][Full Text] [Related]
58. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
[TBL] [Abstract][Full Text] [Related]
59. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
60. Stem cells in breast tumours: are they ready for the clinic?
Ablett MP; Singh JK; Clarke RB
Eur J Cancer; 2012 Sep; 48(14):2104-16. PubMed ID: 22542086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
